IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenström's macroglobulinemia (SWM).

Clin Lymphoma Myeloma Leuk 2011 Feb;11(1):74-6

Mayo Clinic, Rochester, MN, USA.

Monoclonal gammopathy of undetermined significance of IgM class (IgM MGUS) was diagnosed in 213 Mayo Clinic patients who were residents of 11 counties in Southeastern Minnesota from 1960 to 1994. During long-term follow-up 29 (14%) developed non-Hodgkin lymphoma (n=17), Waldenström's macroglobulinemia (n=6), chronic lymphocytic leukemia (n=3), and AL amyloidosis (n=3) with relative risks of 15-, 262-, 6-, and 16-fold, respectively. The cumulative probability of progression to one of these disorders was 10% at 5 years, 18% at 10 years, and 24% at 15 years, approximately 1.5% per year.Forty-eight patients with SWM were identified at Mayo Clinic from 1974 to 1995. During 285 cumulative person-years of follow-up (median, 15.4 years) 34 (71%) progressed to Waldenström's macroglobulinemia (WM), 1 to AL amyloidosis, and 1 to lymphoma (total, 36 [75%]). The cumulative probability of progressing to WM, amyloidosis, or lymphoma was 6% at 1 year, 39% at 3 years, and 59% at 5 years (12% per year).

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLML.2011.n.011DOI Listing
February 2011
20 Reads

Publication Analysis

Top Keywords

waldenström's macroglobulinemia
12
undetermined significance
8
amyloidosis lymphoma
8
gammopathy undetermined
8
mayo clinic
8
monoclonal gammopathy
8
cumulative probability
8
years
6
10% years
4
years 18%
4
disorders 10%
4
24% years
4
yearforty-eight patients
4
patients swm
4
15% yearforty-eight
4
years 15%
4
years 24%
4
progression disorders
4
18% years
4
16-fold cumulative
4

Similar Publications